Pharmacogenomics of coumarin anticoagulants: are we underestimating the role of CYP2C9?

Thromb Haemost. 2008 Aug;100(2):175-6.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anticoagulants / adverse effects*
  • Aryl Hydrocarbon Hydroxylases / genetics*
  • Aryl Hydrocarbon Hydroxylases / metabolism
  • Coumarins / adverse effects*
  • Cytochrome P-450 CYP2C9
  • Drug Resistance / genetics*
  • Hemorrhage / chemically induced
  • Hemorrhage / genetics*
  • Humans
  • Pharmacogenetics
  • Risk Factors

Substances

  • Anticoagulants
  • Coumarins
  • coumarin
  • CYP2C9 protein, human
  • Cytochrome P-450 CYP2C9
  • Aryl Hydrocarbon Hydroxylases